×
Back to Agenda
Session 6: Free Session - Choose Between:
Speaker(s)
Claudine Sapède, PHARMD
Director, Global HTA Policy, NOVARTIS INTERNATIONAL, Switzerland
Session 6 – Value, Access & Regulatory Evidence Workshop: Joint Clinical Assessment (REA)
Robert Hemmings, MSC
, Critical Path Institute, Netherlands
Session 6 – Future of Evidence Workshop: Using Data from Clinical Care for Evidence Generation
Have an account?